Inventor

Linda C. Foster

Inventor
Mountain View, CA, US

Overview

22→
Patents
1994–2006
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61MDevices for introducing media into, or onto, the body17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
B82YSpecific uses or applications of nanostructures10%
C07KPeptides7%
C12NMicroorganisms or enzymes5%
Y02ATechnologies for adaptation to climate change5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
7,097,827'Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments'20066,589,560'Stable glassy state powder formulations'20036,582,728'Spray drying of macromolecules to produce inhaleable dry powders'20036,582,729'Powered pharmaceutical formulations having improved dispersibility'20036,514,496'Dispersible antibody compositions and methods for their preparation and use'20036,509,006'Devices compositions and methods for the pulmonary delivery of aerosolized medicaments'20036,479,049'Methods and compositions for the dry powder formulation of interferons'20026,413,547'Liquid crystal forms of cyclosporin'20026,372,258'Methods of spray-drying a drug and a hydrophobic amino acid'20026,358,530'Powdered pharmaceutical formulations having improved dispersibility'20026,309,671'Stable glassy state powder formulations'20016,303,582'Compositions and methods for nucleic acid delivery to the lung'20016,258,341'Stable glassy state powder formulations'20016,231,851'Methods and compositions for the dry powder formulation of interferons'20016,187,344'Powdered pharmaceutical formulations having improved dispersibility'20016,165,463'Dispersible antibody compositions and methods for their preparation and use'20006,136,346'Powdered pharmaceutical formulations having improved dispersibility'20006,123,936'Methods and compositions for the dry powder formulation of interferons'20006,019,968'Dispersible antibody compositions and methods for their preparation and use'20005,997,848'Methods and compositions for pulmonary delivery of insulin'19995,994,314'Compositions and methods for nucleic acid delivery to the lung'19995,376,369'Vaccine adjuvant'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994Patents assigned to SYNTEX INC (1)· patent assignee history
1994–2006Based in Sunnyvale, CA, US· patent location history
1999–2003Patents assigned to INHALE THERAPEUTIC SYST (17)· patent assignee history
2000Patents assigned to INHALE THERAPEUTICS SYSTEMS IN (1)· patent assignee history
2000–2003Based in Mountain View, CA, US· patent location history
2003–2006Patents assigned to NEKTAR THERAPEUTICS (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INHALE THERAPEUTIC SYST171999–2003
NEKTAR THERAPEUTICS32003–2006
INHALE THERAPEUTICS SYSTEMS IN12000
SYNTEX INC11994
Locations
LocationPatentsSpan
Mountain View, California, US122000–2003
Sunnyvale, California, US101994–2006